Evidence map›Paper›PMID 37601194›Full record

ArticleFrontiers in public health2023

Cervical HPV infection in Yueyang, China: a cross-sectional study of 125,604 women from 2019 to 2022.

Jinfeng Hou, Min Zeng, Chongmei Liu, Bochao Xie, Yu Li, Longyun Wu, Long Zhu, Manqiu Li, Zhihui Zhang, Xiaoyun Zhang and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Jinfeng HouDepartment of Gynecology, Yueyang People's Hospital, Hunan Normal University, Yueyang, China.
Min ZengDepartment of Gynecology, Yueyang People's Hospital, Hunan Normal University, Yueyang, China.
Chongmei LiuDepartment of Gynecology, Yueyang People's Hospital, Hunan Normal University, Yueyang, China.
Bochao XieDepartment of Gynecology, Yueyang People's Hospital, Hunan Normal University, Yueyang, China.
Yu LiDepartment of Gynecology, Yueyang People's Hospital, Hunan Normal University, Yueyang, China.
Longyun WuDepartment of Pathology, Yueyang Central Hospital, Yueyang, China.
Long ZhuDepartment of Pathology, Huarong County People's Hospital of Hunan Province, Yueyang, China.
Manqiu LiDepartment of Pathology, Pingjiang People's Hospital of Hunan Province, Yueyang, China.
Zhihui ZhangDepartment of Pathology, Linxiang People's Hospital of Hunan Province, Yueyang, China.
Xiaoyun ZhangDepartment of Gynecology, Yueyang People's Hospital, Hunan Normal University, Yueyang, China.
Yangqing GeDepartment of Gynecology, Yueyang People's Hospital, Hunan Normal University, Yueyang, China.
Yueyang Second People's Hospital · CNHunan Normal University · CNHunan Provincial People's Hospital · CNShanghai University of Traditional Chinese Medicine · CNThe People's Hospital of LinXia · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Human papillomavirus (HPV) infection is currently the main cause of cervical cancer and precancerous lesions in women. The aim of this study was to investigate the epidemiological characteristics of HPV genotypes among women in Yueyang city and to provide a basis for the prevention and treatment of cervical cancer in this city. Methods: A cross-sectional study was conducted on 125,604 women who had received treatment from eight hospitals in Yueyang city from September 2019 to September 2022. Analysis of the prevalence of HPV in patients. Results: The prevalence of HPV was 20.5% (95%CI: 20.2-20.7%), of which the high-risk type (HR-HPV) accounted for 17.5% (95%CI: 17.3-17.7%) and the low-risk type (LR-HPV) accounted for 5.0% (95%CI: 4.9-5.1%). Among the HR-HPV subtypes, the top five in prevalence, from the highest to the lowest, were HPV52 (5.1%), HPV16(2.7%), HPV58 (2.6%), HPV53 (2.4%), and HPV51 (1.7%). The main LR-HPV infection types were HPV81 (2,676 cases, OR = 2.1%; 95%CI, 2.0-2.1%). Among the infected patients, 19,203 cases (OR = 74.3%; 95%CI, 73.8-74.9%) had a single subtype, 4,673 cases (OR = 18.1%; 95%CI, 17.6-18.6%) had two subtypes, and 1957 cases (OR = 7.6%; 95%CI, 7.3-7.9%) had three or more subtypes. HPV prevalence is highest among women <25 years, 55-64 years and ≥ 65 years of age. Conclusion: The prevalence of HPV in women in Yueyang city was 20.5%, with HR-HPV being dominant. As women aged <25 years, 55-64 years, and ≥ 65 years are at a relatively higher risk, more attention should be paid to them for prevention and control of HPV infections.

Indexed as

Papillomavirus InfectionsUterine Cervical NeoplasmsAlphapapillomavirusChinaCross-Sectional StudiesFemaleHuman Papillomavirus VirusesHumansPapillomaviridaecervical lesionsepidemiologygenotypeshuman papillomavirusprevalence

Identifiers

PMID37601194
PMCPMC10435747
OpenAlexW4385520132

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.